Pustular Psoriasis Overview

Save information for later
Sign Up

Learn About Pustular Psoriasis

What is the definition of Pustular Psoriasis?
Pustular psoriasis is a rare form of psoriasis that is characterized by widespread pustules and reddish skin. This condition can occur alone or with plaque-type psoriasis. Most cases of Pustular psoriasis are thought to be "multifactorial" or associated with the effects of multiple genes in combination with lifestyle and environmental factors. There are several triggers for this conditions including withdrawal from corticosteroids, exposure to various medications and/or infections. Some cases of the generalized form are caused by changes in the IL36RN gene and are inherited in an autosomal recessive pattern. In severe cases, hospitalization may be required.
What are the alternative names for Pustular Psoriasis?
  • Pustular psoriasis
Who are the top Pustular Psoriasis Local Doctors?
Dr. Craig K. Fujisaki
Dermatology
Dr. Craig K. Fujisaki
Dermatology
4509 Talbot Rd S, 
Renton, WA 
 (4.0 mi)
425-917-8580
Languages Spoken:
English, Castilian, Filipino, Mandarin, Spanish, Vietnamese
See accepted insurances
Accepting New Patients
Offers Telehealth

Craig Fujisaki is a Dermatologist in Renton, Washington. Dr. Fujisaki and is rated as an Advanced provider by MediFind in the treatment of Pustular Psoriasis. His top areas of expertise are Generalized Pustular Psoriasis (GPP), Melanoma, Pustular Psoriasis, and Rosacea. Dr. Fujisaki is currently accepting new patients.

Dr. Kerrie J. Spoonemore
Dermatology
Dr. Kerrie J. Spoonemore
Dermatology

Frontier Dermatology - Laurelhurst

3216 Ne 45th Pl, Suite 203, 
Seattle, WA 
 (19.4 mi)
206-525-1168
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Kerrie Spoonemore is a Dermatologist in Seattle, Washington. Dr. Spoonemore and is rated as an Advanced provider by MediFind in the treatment of Pustular Psoriasis. Her top areas of expertise are Sunburn, Pustular Psoriasis, Psoriasis, and Rosacea. Dr. Spoonemore is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Dr. Keith A. Luther
Internal Medicine
Dr. Keith A. Luther
Internal Medicine

Swedish Health Services

3236 78th Ave Se, Suite 200, 
Mercer Island, WA 
 (13.7 mi)
206-275-5060
Languages Spoken:
English, Castilian, Korean, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Keith Luther is an Internal Medicine provider in Mercer Island, Washington. Dr. Luther and is rated as an Experienced provider by MediFind in the treatment of Pustular Psoriasis. His top areas of expertise are Pustular Psoriasis, Rectocele, Asthma in Children, and Asthma. Dr. Luther is currently accepting new patients.

View All Doctors
What are the latest Pustular Psoriasis Clinical Trials?
A Phase IIb, Long-Term Extension Study to Evaluate the Safety and Efficacy of HB0034 in the Treatment of Adult Subjects With Generalized Pustular Psoriasis
A Phase IIb, Long-Term Extension Study to Evaluate the Safety and Efficacy of HB0034 in the Treatment of Adult Subjects With Generalized Pustular Psoriasis
Enrollment Status: Recruiting
Publish Date: February 14, 2025
Intervention Type: Drug
Study Phase: Phase 2/Phase 3

Summary: This is a Phase IIb, long term extension study to evaluate the safety and efficacy of HB0034 in adult subjects with generalized pustular psoriasis (GPP).

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Phase 3, Open-Label, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of TAK-279 in Adult Subjects With Generalized Pustular Psoriasis or Erythrodermic Psoriasis
A Phase 3, Open-Label, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of TAK-279 in Adult Subjects With Generalized Pustular Psoriasis or Erythrodermic Psoriasis
Enrollment Status: Recruiting
Publish Date: January 10, 2025
Intervention Type: Drug
Study Phase: Phase 3

Summary: The main aim of this study is to check if TAK-279 improves symptoms of With Generalized Pustular Psoriasis (GPP) or Erythrodermic Psoriasis (EP) and side effect from the study treatment or TAK-279. All participants will be assigned to study treatments of TAK-279 and will be treated with TAK-279 if the participants meet the study rules. Participants will be in the study for up to 61 weeks including...

View All Clinical Trials
Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center